Disparities in fertility preservation among patients diagnosed with female breast cancer

[1] Oktay K(2018)Fertility preservation in patients with cancer: ASCO clinical practice guideline update J Clin Oncol 36 1994-2001

[2] Harvey BE(2021)Epidemiology of triple-negative breast cancer: a review Cancer J 27 8-16

[3] Partridge AH(2012)Trends of socioeconomic disparities in referral patterns for fertility preservation consultation Hum Reprod 27 2076-2081

[4] Quinn GP(2017)A call for fertility preservation coverage for breast cancer patients: the cost of consistency J Natl Cancer Inst. 109 djx006-666

[5] Reinecke J(2002)Insurance coverage and outcomes of in vitro fertilization N Engl J Med 347 661-73

[6] Taylor HS(2008)Insurance mandates and trends in infertility treatments Fertil Steril 89 66-228

[7] Howard FM(2022)Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment Reprod Biol Endocrinol 20 111-13

[8] Olopade OI(2017)"Joven & Fuerte": program for young women with breast cancer in Mexico -initial results Rev Invest Clin. 69 223-1161

[9] Goodman LR(2017)Viable options for fertility preservation in breast cancer patients: a focus on Latin America Rev Invest Clin. 69 103-91

[10] Balthazar U(2022)Breast cancer grade and stage do not affect fertility preservation outcomes J Assist Reprod Genet 39 1155-2894

[1] Oktay K(2018)Fertility preservation in patients with cancer: ASCO clinical practice guideline update J Clin Oncol 36 1994-2001

[2] Harvey BE(2021)Epidemiology of triple-negative breast cancer: a review Cancer J 27 8-16

[3] Partridge AH(2012)Trends of socioeconomic disparities in referral patterns for fertility preservation consultation Hum Reprod 27 2076-2081

[4] Quinn GP(2017)A call for fertility preservation coverage for breast cancer patients: the cost of consistency J Natl Cancer Inst. 109 djx006-666

[5] Reinecke J(2002)Insurance coverage and outcomes of in vitro fertilization N Engl J Med 347 661-73

[6] Taylor HS(2008)Insurance mandates and trends in infertility treatments Fertil Steril 89 66-228

[7] Howard FM(2022)Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment Reprod Biol Endocrinol 20 111-13

[8] Olopade OI(2017)"Joven & Fuerte": program for young women with breast cancer in Mexico -initial results Rev Invest Clin. 69 223-1161

[9] Goodman LR(2017)Viable options for fertility preservation in breast cancer patients: a focus on Latin America Rev Invest Clin. 69 103-91

[10] Balthazar U(2022)Breast cancer grade and stage do not affect fertility preservation outcomes J Assist Reprod Genet 39 1155-2894